Peter Hoyer
Affiliations: | Physics and Astronomy | University of Calgary, Calgary, Alberta, Canada |
Area:
Theory Physics, Computer Science, Optics PhysicsGoogle:
"Peter Hoyer"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gross O, Tönshoff B, Weber LT, et al. (2020) A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome. Kidney International |
| Gellermann J, Weber L, Pape L, et al. (2013) Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. Journal of the American Society of Nephrology : Jasn. 24: 1689-97 |
| Plotnicki L, Kohl CD, Höcker B, et al. (2013) The CERTAIN Registry: a novel, web-based registry and research platform for pediatric renal transplantation in Europe. Transplantation Proceedings. 45: 1414-7 |
| Maecker B, Jack T, Zimmermann M, et al. (2007) CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 4902-8 |
| Johnston A, Belitsky P, Frei U, et al. (2004) Potential clinical implications of substitution of generic cyclosporine formulations for cyclosporine microemulsion (Neoral) in transplant recipients. European Journal of Clinical Pharmacology. 60: 389-95 |
| Pollard S, Nashan B, Johnston A, et al. (2003) A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001. Clinical Therapeutics. 25: 1654-69 |